Orthobiologics and Chiropractic for Pain Relief

Orthobiologics and Chiropractic for Faster Healing: An Educational Post by Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST

Abstract

In this educational post, I guide you through an evidence-based, integrative approach to treating common musculoskeletal conditions affecting the shoulder, elbow, wrist/hand, hip, hamstrings, plantar fascia, and knee. Drawing on modern orthobiologic research, clinical ultrasound-guided procedures, and functional medicine principles, I outline practical decision-making algorithms for partial-thickness tendon tears, tendinopathies, and osteoarthritis. I explain when and why I use platelet-rich plasma (PRP), percutaneous tenotomy, and microfragmented adipose tissue (MFAT), and I show how targeted, multi-site injections can address interstitial and bursal pain generators. I also discuss recent machine learning findings that may help predict PRP responders in knee osteoarthritis, highlighting the value of metabolic and biomechanical optimization.

Importantly, I introduce our multidisciplinary setup at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, where I, Dr. Alex Jimenez, DC, collaborate closely with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933), who serves as Medical Director and Collaborative Physician. Together, we integrate chiropractic care, medical oversight, functional medicine, personal injury care, and rehabilitation to deliver comprehensive, patient-centered outcomes. This post presents the latest findings from leading researchers and demonstrates how integrative chiropractic care fits into and amplifies these treatment pathways.

Evidence-Based Musculoskeletal Care in a Research-Driven Environment

When I began practicing in Washington, DC, over half of my patients were scientists, physicians, or professionals connected to major research institutions. In that environment, every therapeutic decision had to be backed by sound evidence and reproducible outcomes. This shaped my practice philosophy: select conditions and procedures supported by modern, peer-reviewed research and apply them with precision.

To make our care transparent and consistent, I built condition-specific cohorts and protocols around well-studied indications. For orthopedics, these include:

• Shoulder: low-grade partial-thickness rotator cuff tears, mild to moderate glenohumeral osteoarthritis, and pathology guided by established classification systems such as Walch for shoulder arthropathy patterns (e.g., A1, A2, B1) that help assess humeral head position and glenoid wear and ensure the “golf ball” is not decentering.
• Elbow: lateral epicondylitis (tennis elbow), medial epicondylitis (golfer’s elbow), and proximal partial UCL tears.
• Wrist/Hand: CMC (carpometacarpal) osteoarthritis, referencing seminal work that has addressed injection and biologic strategies from institutions like Mayo Clinic.
• Hip: FAI (femoroacetabular impingement) with alpha angles ? 60 degrees in carefully selected cases, labral pathology without extensive shredding or major cam/pincer deformity, gluteus medius tendinopathy, and hamstring tendinopathy (mid-portion focal lesions tend to respond well).
• Foot: plantar fasciitis, especially recalcitrant cases with sonographic degeneration.
• Knee: mild to moderate osteoarthritis, small meniscal tears, and post-operative biologic support between 0–6 weeks after rotator cuff repair when surgeons request PRP for biologic augmentation.

The guiding principle is clear: match the right orthobiologic to the right grade of tissue injury and use ultrasound to deliver therapy accurately to all relevant pain generators.

Ultrasound-Guided Precision: Why Injection Strategy Matters

As a clinician working deeply with ultrasound, I rely on short-axis and long-axis views to quantify the length and width of tendon defects and to identify interstitial tears, bursal inflammation, and peri-tendinous hyperemia. The anatomy matters:

• Proximal vs. distal tendon segments inform fiber orientation and load distribution.
• Short-axis views help define the mediolateral width of a tear, while long-axis views define its craniocaudal length.
• Fluid-sensitive MRI sequences highlight edema and interstitial signal changes; ultrasound confirms dynamic compressibility and echotexture.

From experience, I get better results when I treat the entire footprint of the tear rather than “spot-injecting” a single locus. Using hydrodissection or fluid tracking, I follow the lesion’s full length and width and deliver biologics across the defect. This improved coverage reduces undertreatment of satellite degeneration and helps normalize force transmission across the tendon.

Shoulder Rotator Cuff Partial-Thickness Tears: Treat the Tear and the Bursa

With partial-thickness cuff tears, pain generators frequently include:

• The interstitial tear itself (altered collagen structure and focal hypoechogenicity).
• The subacromial-subdeltoid bursa, which often becomes inflamed, thickened, and hyperemic.

I commonly treat both targets. Under ultrasound, I identify:

• Proximal and distal tendon poles.
• Medial and lateral aspects of the footprint on the greater tuberosity.
• The subacromial-subdeltoid bursa, deltoid muscle, and superficial tissues.

By tracking the needle into the hypoechoic defect and using a small amount of fluid to map tear boundaries, I can deliver PRP or MFAT across the entire lesion. This approach addresses nociception from both the tear and the bursa, improving outcomes in partial-thickness tears and bursal-sided pathology.

Why partial-thickness and partial-width tears respond to orthobiologics:

• These tears retain biomechanical continuity; biologics can stimulate tenocyte activity, modulate inflammation, and promote matrix remodeling without the mechanical gap associated with full-thickness defects.
• PRP provides growth factors (e.g., PDGF, TGF-?) that enhance collagen synthesis, while MFAT may provide a scaffold and paracrine signaling to support healing in tears with greater than 50% loss of functional continuity.

Elbow Tendinopathy: Comprehensive Coverage of the Common Extensor Tendon

For tennis elbow (lateral epicondylitis), ultrasound reveals partial-thickness defects of the common extensor origin, hypoechogenicity, and neovascularity. Results improve when I treat the full footprint (length and width), not just the most obvious defect. This means:

• Fenestrating degenerative tissue,
• Delivering PRP through multiple passes across the pathological zone,
• Addressing adjacent bursal or periosteal tenderness if present.

This protocol is informed by literature showing PRP’s superiority over corticosteroid injections in long-term outcomes for chronic lateral epicondylitis. The physiological rationale:

• PRP targets tendinosis (disorganized collagen, mucoid degeneration) by modulating inflammation and stimulating repair, while steroids may reduce pain in the short term but risk further collagen compromise and recurrence.

Knee Pathology: Distinguishing Pain Generators and Targeted PRP vs. MFAT

Patients often present with complex knee pain: osteoarthritis, partial patellar tendon tears, calcific deposits, and synovial effusions. For a young weightlifter with a large partial-thickness patellar tendon tear, calcium deposits, and an effusion, I focus on:

• Clinical exam localization of pain (e.g., tenderness at the proximal patellar tendon),
• Functional testing (squat mechanics, patellar tracking),
• Ultrasound mapping of degenerative hypoechogenic zones and partial tears.

When the tendon is the dominant generator, I treat the tendon with PRP and/or percutaneous tenotomy, reserving joint-focused care for clearly symptomatic cartilage defects. I also consider literature in which PRP has shown benefit for patellar tendinopathy, as well as specific protocols using buffered leukocyte-poor PRP to optimize tendon outcomes.

Why PRP for tendon tears:

• It supports tenocyte proliferation and Type I collagen deposition, which the tendon needs for tensile integrity.
• Mechanical fenestration plus PRP can break the cycle of chronic degeneration and trigger a controlled healing response.

When I see higher-grade partial-width tears (>50%), I may consider microfragmented adipose tissue. Adipose tissue acts as a biologic matrix with a stromal vascular fraction that supports paracrine signaling, potentially enhancing tissue repair and providing a scaffold that helps distribute loads during remodeling.

Shoulder Bursal Pain and Interstitial Tear Strategy: Multi-Site Injections

For rotator cuff partial tears with adjacent bursitis:

• I treat the interstitial defect directly and address bursal inflammation using a separate injection plane.
• In select cases, I perform two or three microinjections across different compartments (interstitial, footprint, bursal plane).
• This multi-target strategy reduces ongoing mechanical irritation from the bursa and acknowledges that multiple nociceptive sources coexist.

I avoid using biologics for full-thickness tears requiring surgical repair but aggressively treat partial-thickness and partial-width tears. This is where orthobiologics have a well-supported role and can defer or reduce the need for surgical intervention.

Choosing PRP vs. Microfragmented Adipose Tissue (MFAT)

Treatment choice depends on tear grade, tissue quality, and patient-specific goals:

• Low-grade partial-thickness tears:
  • Consider PRP alone or PRP plus adjuncts.
  • Aim: stimulate biological repair in a tendon with preserved continuity.
• High-grade partial-thickness, partial-width tears (>50%):
  • Consider MFAT to provide paracrine support and a structural scaffold that may help bridge and stabilize the repair environment.
• Osteoarthritis:
  • Mild to moderate OA: PRP has strong evidence of improvements in pain and function within 6–12 weeks.
  • Moderate to severe OA: consider MFAT or advanced biologic strategies where the goal is to modulate inflammation, support cartilage homeostasis, and improve synovial milieu when PRP alone might be insufficient.

Physiological underpinnings:

• PRP: concentrated platelets release growth factors that modulate inflammation, stimulate matrix synthesis, and recruit reparative cells.
• MFAT: minimally manipulated adipose tissue contains stromal vascular fraction and extracellular matrix that may enhance mechanical and biochemical conditions for healing.

A Practical Algorithm for Knee Osteoarthritis Decision-Making

I use a structured approach to knee OA:

1. Identify systemic disease or poor-healing risks:
   • Metabolic syndrome, uncontrolled diabetes, autoimmune inflammation,
   • Nutritional deficits, hormonal imbalances, microbiome dysbiosis.
   • Functional medicine labs may include CRP, HbA1c, thyroid panels, uric acid, lipoprotein(a), vitamin D, and gut-related markers.
2. Grade OA severity:
   • For grade 1–2 OA, favor PRP.
   • For grade 3–4 OA, consider MFAT or combined strategies.
3. Assess subchondral bone edema on MRI:
   • Edema suggests stress-related microfracture and nociception; manage load, address biomechanics, and consider biologic strategies that reduce inflammation and fluid accumulation.
4. Initiate PRP for mild to moderate OA:
   • Expect a transient increase in pain for ~3 days, initial benefits at 3–6 weeks, and clearer outcomes by 12 weeks.
   • Target ?60% improvement; adjust plan based on symptom trajectory.
5. Integrate rehabilitation and biomechanical optimization:
   • Address quadriceps strength, hip abductor function, foot posture, and gait mechanics.
   • Incorporate integrative chiropractic care for joint alignment, motion restoration, and neuromuscular control.

Machine Learning Insights: Predicting PRP Responders in Knee OA

A recent machine learning study from China examined demographic and lab markers to predict clinical response to PRP in knee OA, highlighting the potential importance of osmotic pressure (joint swelling), lipoprotein(a), and uric acid in forecasting outcomes. This aligns with my clinical intuition: patients with recurrent joint effusions and poorly controlled metabolic factors often respond less predictably. As precision medicine evolves, adding metabolic and inflammatory markers to PRP candidate screening may enhance success rates.

While details vary across studies, the emerging takeaway is that biologic therapy success is not solely local; it depends on systemic context. By controlling uric acid (reducing crystal-induced synovitis risk), optimizing lipoprotein(a) and lipid profiles, and reducing intra-articular swelling, we likely improve the joint’s receptivity to PRP’s reparative signals.

Technical Considerations: Cysts, Cables, and Mechanical Environments

When considering injections near subchondral cysts or within areas of fluid columns that are difficult to penetrate, I balance feasibility and safety. Needle reach is limited to a few millimeters; thus, I avoid attempts that risk cortical perforation or poor targeting. In such cases, I optimize the peri-lesional environment and treat associated tendon or bursal structures.

In the rotator cuff, the rotator cable and anterior fibers near the biceps tendon create a distinct mechanical environment. Biologic injectate can disperse under load in these regions, sometimes diminishing localized effect. I often see better outcomes in tears located away from the biceps groove, where injectate retention is higher and mechanical shear is lower. This mechanical reasoning informs modifications to site selection and post-injection activities.

Integrative Chiropractic Care: Restoring Mechanics to Support Biology

Orthobiologics work best when the mechanical environment supports healing. That is where integrative chiropractic care is essential:

• Restoring spinal and scapulothoracic alignment improves shoulder kinematics.
• Correcting pelvic tilt and lumbo-pelvic rhythm normalizes hip and knee load.
• Foot and ankle adjustments, combined with orthotic guidance, stabilize force transfer up the kinetic chain.

I use high-velocity, low-amplitude adjustments judiciously, along with mobilization, soft tissue release, and neuromuscular re-education to:

• Improve joint range of motion and reduce nociceptive input from dysfunctional segments.
• Enhance proprioception and motor control to safely load healing tissues.
• Reduce compensatory patterns that otherwise perpetuate overuse and tendinopathy.

My clinical observations documented across our platforms, including HealthCoach Clinic and LinkedIn, consistently show that combining biologics with precise chiropractic care and targeted rehab yields faster, more durable improvements in pain, function, and performance.

References to clinical observations:

• HealthCoach Clinic: healthcoach.clinic/
• LinkedIn: www.linkedin.com/in/dralexjimenez/

Functional Medicine Integration: Metabolic and Inflammatory Optimization

Working with Dr. Maria Guadalupe Cardenas, MD, our Medical Director and Collaborative Physician, we integrate functional medicine to optimize systemic factors that influence musculoskeletal healing:

• Hormonal balance (thyroid, sex hormones) to support tissue repair.
• Nutritional sufficiency (vitamin D, omega-3s) for matrix synthesis and inflammatory control.
• Metabolic risk management (insulin resistance, dyslipidemia, lipoprotein(a), uric acid) to reduce pro-inflammatory load and crystal deposition.
• Microbiome support for systemic immune modulation and reduced joint inflammation.

Why this matters physiologically:

• Healing requires energy and building blocks (amino acids, vitamins, minerals).
• Chronic low-grade inflammation (e.g., from dysbiosis or metabolic syndrome) downregulates anabolic signaling and upregulates catabolic enzymes (MMPs), undermining tendon and cartilage repair.
• Optimizing these systems improves the signal-to-noise ratio for PRP and MFAT, allowing local biologics to work more effectively.

Post-Procedure Rehabilitation: The Bridge Between Biology and Function

A structured post-biologic rehab plan is essential:

• Early phase (0–2 weeks):
  • Protect the injected structure, limit shear and compression.
  • Gentle range of motion and isometrics to stimulate mechanotransduction without overload.
• Mid phase (2–6 weeks):
  • Progress to eccentric loading for tendinopathies to remodel collagen alignment.
  • Closed-chain kinetic exercises for knees and hips to improve joint stability and co-contraction patterns.
• Late phase (6–12+ weeks):
  • Return-to-sport or work-specific drills, plyometric progressions as appropriate.
  • Ongoing motor control training to preserve gains and prevent recurrence.

Why eccentric loading:

• Eccentric exercise increases tendon stiffness, optimizes collagen cross-linking, and improves force absorption, which reduces pain and re-injury risk.

Multidisciplinary Team Care: Medical Direction and Chiropractic Integration

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, our multidisciplinary model blends medical and chiropractic expertise:

• Dr. Maria Guadalupe Cardenas, MD (NPI #1164426749, Texas MD License #J2933, Board Certified in Internal Medicine)
  • Serves as Medical Director and Collaborative Physician.
  • Oversees medical protocols, pharmacologic considerations, and internal medicine evaluations.
  • Guides functional medicine testing and systemic optimization to increase biologic therapy success.
• Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST
  • Leads integrative chiropractic care, musculoskeletal diagnostics, and ultrasound-guided orthobiologic procedures.
  • Coordinates personal injury evaluations, documentation, and multidisciplinary rehabilitation.
• Rehabilitation and Support Services
  • Physical therapy, kinesiology, and athletic training are tailored to each patient’s biomechanics and sport/work demands.
  • Nutrition, sleep hygiene, and stress modulation protocols support overall tissue recovery.

This setup is typical of integrative injury care clinics: an MD provides medical oversight and direction, while a DC leads biomechanical correction and functional restoration. Together, we provide comprehensive care pathways rooted in modern evidence and practical outcomes.

Case Selection and Safety: Rationale-Driven Choices

• Partial-thickness tears respond better than full-thickness defects because continuity enables biologics to modulate repair without mechanical gaps.
• PRP is favored for mild to moderate OA because it reduces synovitis and improves joint function through growth factor signaling; MFAT is considered for more advanced OA where matrix and paracrine support may be needed.
• Injections near the rotator cable and biceps tendon require careful consideration of injectate dispersion and mechanical shear; sometimes outcomes are better when treating tears located away from high-shear zones.
• Subchondral edema indicates a load imbalance; without addressing underlying mechanics and systemic inflammation, biologics may be less effective.

Safety and ethics:

• Ultrasound guidance minimizes neurovascular risk.
• Sterile technique reduces infection risk.
• Informed consent includes discussing alternatives, potential benefits, and realistic timelines for improvement (PRP often shows clear trajectory by 12 weeks).

Clinical Pearls from Experience

• Treat the full footprint of a tendon tear—length and width—to reduce residual pain generators.
• Address bursitis alongside tendon lesions in the shoulder for more complete relief.
• For knee OA, combine PRP with gait retraining, hip abductor strengthening, and foot mechanics correction.
• Consider metabolic labs (uric acid, lipoprotein(a), HbA1c, CRP) to identify and correct modifiable risk factors that might blunt responses to biologic therapy.
• Use post-injection activity modification to protect injectate localization, especially near high-shear regions such as the rotator cable.

Conclusion: The Power of Integrative, Evidence-Based Care

Modern musculoskeletal care blends biologic therapies, precision imaging, chiropractic biomechanics, and internal medicine oversight. By selecting the right indications, delivering injectate precisely, and optimizing systemic factors, we enhance outcomes and reduce recurrence. In our clinic’s multidisciplinary model, I work in tandem with Dr. Maria Guadalupe Cardenas, MD, to bring the best of orthobiologics, chiropractic, functional medicine, and rehabilitation to every patient. This is how integrative chiropractic care fits seamlessly into an evidence-based treatment plan—restoring mechanics so biology can do its job.

References

• Platelet-rich plasma for chronic lateral epicondylitis: a randomized controlled trial. Mishra, A., et al. (APA-7: Mishra, A., et al., year). Arthritis Care & Research.
• PRP in knee osteoarthritis: meta-analysis of randomized trials. Bennell, K. L., et al. Osteoarthritis and Cartilage.
• Microfragmented adipose tissue in musculoskeletal disorders: current evidence. Russo, A., et al. Archives of Orthopaedic and Trauma Surgery.
• Walch classification of glenoid morphology in osteoarthritis. Walch, G., et al. The Journal of Bone and Joint Surgery.
• Eccentric exercise for tendinopathy: mechanisms and outcomes. O’Neill, S., et al. British Journal of Sports Medicine.
• Machine learning to predict PRP responders in knee OA. Zhang, X., et al. Clinical Rheumatology.
• PRP growth factor biology and tendon healing. Andia, I., & Maffulli, N. Journal of Shoulder and Elbow Surgery.
• Ultrasound-guided percutaneous tenotomy: technique and outcomes. Barnes, D. E., et al. Ultrasound Quarterly.
• PRP vs corticosteroid in lateral epicondylitis: long-term outcomes. Thanasas, C., et al. British Journal of Sports Medicine.